{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:29:07Z","timestamp":1793802547705,"version":"4.6.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Excessive use of head computed tomography (CT) in mild traumatic brain injury (TBI) increases radiation exposure and contributes to emergency department crowding. Blood biomarkers glial fibrillary acid protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) may improve risk stratification and guide clinical decision-making. We evaluated the diagnostic accuracy and prognostic value of a dual GFAP\/UCH-L1 test, GFAP, and UCH-L1\u2014individually and jointly\u2014for detecting acute intracranial injury and predicting mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective observational study at a tertiary hospital from March 10, 2023, to March 31, 2025. Adult patients presenting within 12 h of mild TBI (Glasgow Coma Scale score 13 to 15) with available serum GFAP and UCH-L1 measurements were included. Biomarker concentrations were measured on the Alinity i. Dual GFAP\/UCH-L1 test positivity was defined as GFAP \u226535 pg\/mL and\/or UCH-L1 \u2265400 pg\/mL. The primary outcome was acute intracranial injury on head CT. Diagnostic performance was assessed using CT as the reference standard. Secondary outcomes were 30- and 90-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2932 patients were included (median age 83 years; 57% women). Intracranial injury was identified in 230 patients (7.8%). The dual GFAP\/UCH-L1 test showed high sensitivity (97.4%) and negative predictive value (98.6%). GFAP demonstrated better discrimination (area under the receiver operating characteristic [ROC] curve [AUC] 0.768) than UCH-L1 (AUC 0.642) and GFAP + UCH-L1 (0.742). In multivariable analysis, dual GFAP\/UCH-L1 test positivity (odds ratio [OR] 7.28) independently predicted intracranial injury. UCH-L1 was associated with 30 day (hazard ratio [HR] 1.00028) and 90-day mortality (HR 1.00022).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The dual GFAP\/UCH-L1 test provides strong rule-out accuracy for acute intracranial injury, while UCH-L1 offers meaningful prognostic information. Biomarker guided assessment may reduce unnecessary CT use and support early risk stratification in emergency care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfag110","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:52:47Z","timestamp":1784548367000},"page":"1378-1391","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Accuracy and Prognostic Value of the Dual GFAP\/UCH-L1 Test in Patients Presenting to the Emergency Department with Mild Traumatic Brain Injury"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-8608","authenticated-orcid":false,"given":"Miriam","family":"Menacho-Roman","sequence":"first","affiliation":[{"name":"Universidad de Alcala, Madrid ,","place":["Spain"]},{"name":"Clinical Biochemistry Department, University Hospital Ramon y Cajal, IRYCIS, Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Morales Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Emergency Department, University Hospital Ramon y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Roberto","family":"Penedo Alonso","sequence":"additional","affiliation":[{"name":"Emergency Department, University Hospital Ramon y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Pecharrom\u00e1n de las Heras","sequence":"additional","affiliation":[{"name":"Radiodiagnostic Department, University Hospital Ramon y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Vicente Bartulos","sequence":"additional","affiliation":[{"name":"Radiodiagnostic Department, University Hospital Ramon y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Arribas-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Universidad de Alcala, Madrid ,","place":["Spain"]},{"name":"Clinical Biochemistry Department, University Hospital Ramon y Cajal, IRYCIS, Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2026110408532225800_jfag110-B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management","volume":"104","author":"Capizzi","year":"2020","journal-title":"Med Clin North Am"},{"key":"2026110408532225800_jfag110-B2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.apmr.2019.10.179","article-title":"Management of concussion and mild traumatic brain injury: a synthesis of practice guidelines","volume":"101","author":"Silverberg","year":"2020","journal-title":"Arch Phys Med Rehabil"},{"key":"2026110408532225800_jfag110-B3","doi-asserted-by":"crossref","first-page":"e0173798","DOI":"10.1371\/journal.pone.0173798","article-title":"A blood-based biomarker panel to risk-stratify mild traumatic brain injury","volume":"12","author":"Sharma","year":"2017","journal-title":"PLoS One"},{"key":"2026110408532225800_jfag110-B4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/jama.294.12.1511","article-title":"Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injury","volume":"294","author":"Stiell","year":"2005","journal-title":"JAMA"},{"key":"2026110408532225800_jfag110-B5","first-page":"e86","article-title":"ACEP\u2019s recommendations for brain computed tomography scan in adult minor head trauma patients: a diagnostic accuracy study","volume":"8","author":"Mohammaddoust","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"2026110408532225800_jfag110-B6","author":"National Institute for Health and Care Excellence"},{"key":"2026110408532225800_jfag110-B7","doi-asserted-by":"crossref","first-page":"e221302","DOI":"10.1001\/jamanetworkopen.2022.1302","article-title":"Evaluation of glial and neuronal blood biomarkers compared with clinical decision rules in assessing the need for computed tomography in patients with mild traumatic brain injury","volume":"5","author":"Papa","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026110408532225800_jfag110-B8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/01.WNL.0000120550.00643.DC","article-title":"Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury","volume":"62","author":"Vos","year":"2004","journal-title":"Neurology"},{"key":"2026110408532225800_jfag110-B9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/brbi.2001.0646","article-title":"Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression","volume":"15","author":"Webster","year":"2001","journal-title":"Brain Behav Immun"},{"key":"2026110408532225800_jfag110-B10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","article-title":"Glial fibrillary acidic protein: GFAP\u2014thirty\u2014one years (1969-2000)","volume":"25","author":"Eng","year":"2000","journal-title":"Neurochem Res"},{"key":"2026110408532225800_jfag110-B11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03256432","article-title":"A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury","volume":"16","author":"Schiff","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"2026110408532225800_jfag110-B12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","article-title":"Glial fibrillary acidic protein isoform expression in plaque-related astrogliosis in Alzheimer\u2019s disease","volume":"35","author":"Kamphuis","year":"2014","journal-title":"Neurobiol Aging"},{"key":"2026110408532225800_jfag110-B13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2010.09.020","article-title":"Inflammation and gliosis in neurological diseases: clinical implications","volume":"231","author":"Cz\u0142onkowska","year":"2011","journal-title":"J Neuroimmunol"},{"key":"2026110408532225800_jfag110-B14","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1523\/JNEUROSCI.5384-11.2012","article-title":"Alexander disease","volume":"32","author":"Messing","year":"2012","journal-title":"J Neurosci"},{"key":"2026110408532225800_jfag110-B15","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1523\/JNEUROSCI.3260-06.2006","article-title":"Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response","volume":"26","author":"Hagemann","year":"2006","journal-title":"J Neurosci"},{"key":"2026110408532225800_jfag110-B16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yexcr.2014.02.024","article-title":"The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid","volume":"322","author":"Pierozan","year":"2014","journal-title":"Exp Cell Res"},{"key":"2026110408532225800_jfag110-B17","doi-asserted-by":"crossref","first-page":"e80779","DOI":"10.1371\/journal.pone.0080779","article-title":"Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"2026110408532225800_jfag110-B18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(99)02224-6","article-title":"GFAP phosphorylation studied in digitonin-permeabilized astrocytes: standardization of conditions","volume":"853","author":"Karl","year":"2000","journal-title":"Brain Res"},{"key":"2026110408532225800_jfag110-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/neu.2012.2762","article-title":"Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury","volume":"30","author":"Zoltewicz","year":"2013","journal-title":"J Neurotrauma"},{"key":"2026110408532225800_jfag110-B20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2353\/ajpath.2006.050798","article-title":"Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer\u2019s disease brain","volume":"168","author":"Mouser","year":"2006","journal-title":"Am J Pathol"},{"key":"2026110408532225800_jfag110-B21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"2026110408532225800_jfag110-B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fneur.2019.00027","article-title":"Biomarkers in spinal cord injury: prognostic insights and future potentials","volume":"10","author":"Albayar","year":"2019","journal-title":"Front Neurol"},{"key":"2026110408532225800_jfag110-B23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pjnns.2018.02.002","article-title":"Looking for novel, brain-derived, peripheral biomarkers of neurological disorders","volume":"52","author":"Chmielewska","year":"2018","journal-title":"Neurol Neurochir Pol"},{"key":"2026110408532225800_jfag110-B24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/prca.200800011","article-title":"Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation","volume":"2","author":"Kobeissy","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"2026110408532225800_jfag110-B25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14728222.2017.1321635","article-title":"Ubiquitin C-terminal hydrolase-L1 as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"2026110408532225800_jfag110-B26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4103\/1673-5374.184482","article-title":"Modification of ubiquitin C-terminal hydrolase L1 by reactive lipid species: role in neural regeneration and diseases of aging","volume":"11","author":"Graham","year":"2016","journal-title":"Neural Regen Res"},{"key":"2026110408532225800_jfag110-B27","doi-asserted-by":"crossref","first-page":"36140","DOI":"10.1074\/jbc.M114.557124","article-title":"The ubiquitin C-terminal hydrolase L1 C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons","volume":"289","author":"Bishop","year":"2014","journal-title":"J Biol Chem"},{"key":"2026110408532225800_jfag110-B28","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M314124200","article-title":"Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"279","author":"Choi","year":"2004","journal-title":"J Biol Chem"},{"key":"2026110408532225800_jfag110-B29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12640-013-9377-4","article-title":"Increased generation of cyclopentenone prostaglandins after brain ischemia and their role in aggregation of ubiquitinated proteins in neurons","volume":"24","author":"Liu","year":"2013","journal-title":"Neurotox Res"},{"key":"2026110408532225800_jfag110-B30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/1389203717666160217143721","article-title":"Familial mutations and post-translational modifications of UCH-L1 in Parkinson\u2019s disease and neurodegenerative disorders","volume":"18","author":"Lee","year":"2017","journal-title":"Curr Protein Pept Sci"},{"key":"2026110408532225800_jfag110-B31","doi-asserted-by":"crossref","first-page":"105477","DOI":"10.1016\/j.ebiom.2024.105477","article-title":"An automated blood test for glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) to predict the absence of intracranial lesions on head CT in adult patients with mild traumatic brain injury: BRAINI, a multicentre observational study in Europe","volume":"110","author":"Lagares","year":"2024","journal-title":"EBioMedicine"},{"key":"2026110408532225800_jfag110-B32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.annemergmed.2025.03.018","article-title":"Can the association of the biomarkers GFAP and UCH-L1 predict intracranial injury after mild traumatic brain injury in adults? A systematic review and meta-analysis","volume":"87","author":"Puravet","year":"2026","journal-title":"Ann Emerg Med"},{"key":"2026110408532225800_jfag110-B33","first-page":"1705","article-title":"Implications of the 2021 CKD-EPI eGFR equation without race in a European population: a retrospective cohort study","volume":"16","author":"Fu","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026110408532225800_jfag110-B34","first-page":"1603","article-title":"The quest for accurate and equitable GFR estimation: are we there yet?","volume":"16","author":"Shafi","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026110408532225800_jfag110-B35","doi-asserted-by":"crossref","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026110408532225800_jfag110-B36","author":"R Core Team"},{"key":"2026110408532225800_jfag110-B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v014.i09","article-title":"The R commander: a basic-statistics graphical user interface to R","volume":"14","author":"Fox","year":"2005","journal-title":"J Stat Softw"},{"key":"2026110408532225800_jfag110-B38","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"2026110408532225800_jfag110-B39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"2026110408532225800_jfag110-B40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/diagnostics15091093","article-title":"Age-adjusted cut-off values for glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1 improve the diagnostic accuracy of the Abbott mild traumatic brain injury assay","volume":"15","author":"Lapi\u0107","year":"2025","journal-title":"Diagnostics"},{"key":"2026110408532225800_jfag110-B41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/cclm-2024-1034","article-title":"Increased specificity of the GFAP\/UCH-L1 mTBI rule-out test by age-dependent cut-offs","volume":"63","author":"Ladang","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"2026110408532225800_jfag110-B42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jalm.2019.031393","article-title":"Predictive performance of traumatic brain injury biomarkers in high-risk elderly patients","volume":"5","author":"Ward","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026110408532225800_jfag110-B43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/acem.14366","article-title":"Accuracy of a rapid glial fibrillary acidic protein\/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury","volume":"28","author":"Bazarian","year":"2021","journal-title":"Acad Emerg Med"},{"key":"2026110408532225800_jfag110-B44","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/jcm14124095","article-title":"Budget impact analysis of the use of specific biomarkers GFAP and UCH-L1 in the management of mild traumatic brain injury in Spain","volume":"14","author":"Moya Torrecilla","year":"2025","journal-title":"J Clin Med"},{"key":"2026110408532225800_jfag110-B45","first-page":"31","article-title":"Traumatismo craneoencef\u00e1lico leve y biomarcadores de lesi\u00f3n cerebral aguda","volume":"3","author":"Temboury","year":"2024","journal-title":"Rev Esp Urg Emerg"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/6\/1378\/69549310\/jfag110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/6\/1378\/69549310\/jfag110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:53:31Z","timestamp":1793800411000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/6\/1378\/8738065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,7,20]]},"published-print":{"date-parts":[[2026,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfag110","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,7,20]]}}}